Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlobeImmune
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with chronic hepatitis C virus infection including treatment naive subjects as well as subjects who are partial responders and relapsers to prior interferon therapy
\>18 years of age
Negative skin test for hypersensitivity to saccharomyces cerevisiae.
You may not be if
Non-responders to previous interferon treatments
Cirrhosis
HCV treatment within 3 months
Hepatitis B infection
HIV infection
Clareo Health | Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection
